• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Gilead Sciences

Anonymous board for Gilead Sciences

Sticky threads

Normal threads

Replies
19
Views
2K
anonymous
Replies
64
Views
8K
anonymous
Replies
16
Views
3K
Replies
31
Views
8K
anonymous
Replies
15
Views
2K
anonymous
Replies
47
Views
11K
anonymous
  • New replies moderating enabled
Replies
38
Views
6K
anonymous
Replies
5
Views
1K
anonymous
ACS
Replies
35
Views
2K
anonymous
Replies
9
Views
6K
anonymous
Replies
0
Views
586
anonymous
Replies
23
Views
5K
Kiteflyer
Replies
213
Views
22K
anonymous
Replies
34
Views
4K
anonymous
MYM
Replies
7
Views
959
anonymous
Replies
9
Views
2K
anonymous